Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Chinese Postmenopausal Osteoporosis (Phase 3)
CTR20130903Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in osteoporosis, sponsored by Amgen. Started May 2014; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20130903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130903.